Enoxaparin sodium T22323
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI)
CAS nr:
679809-58-6
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Proteases/Proteasome
Target:
Thrombin
